ctrl K

Price Alert

Drugs Made In America Acq... (DMAA)

NASDAQ: DMAA · Real-Time Price · USD

10.27

0.00 (0.00%)

At close: Aug 21, 2025, 3:59 PM

Drugs Made In America Acquisition Ordinary Shares Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash & Equivalents	822.00	923.00	1.35K	2.1K	18.10
Short-Term Investments	n/a	n/a	1.35K	n/a	n/a
Long-Term Investments	n/a	233.59M	n/a	n/a	n/a
Other Long-Term Assets	235.16M	-852.38K	545.83	424.04K	112.96
Receivables	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	48.9K	n/a	-4.99K	n/a	n/a
Total Current Assets	49.73K	71.02K	4.99	2.1K	78.10
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	235.16M	232.74M	545.83	424.04K	112.96
Total Assets	235.21M	232.81M	550.82	426.14K	191.06
Account Payables	147.45K	132.48K	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	60.9K	662.32	552.01K	210.09
Other Current Liabilities	n/a	n/a	56.06	38.98K	0.90
Total Current Liabilities	301.44K	347.37K	795.67	591K	210.99
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	6.9M	6.9M	n/a	n/a	n/a
Total Long-Term Liabilities	6.9M	6.9M	n/a	n/a	n/a
Total Liabilities	7.2M	7.25M	795.67	591K	210.99
Total Debt	n/a	60.9K	662.32	552.01K	210.09
Common Stock	235.16M	232.74M	986.00	986.00	0.99
Retained Earnings	-6.46M	-6.33M	-279	-199.86K	-54.93
Comprehensive Income	n/a	n/a	n/a	n/a	-0.00
Shareholders Equity	228M	225.56M	-244	-164.86K	-19.93
Total Investments	n/a	233.59M	1.35K	n/a	n/a